drugset / Trial / NCT07607483
A Study of LY4065967 in Healthy Participants
RandomizedCrossoverOpen-labelBasic science
Summary
The main purpose of this study is to compare 3 different forms of LY4065967 - a tablet and 2 types of capsule - to see how much and how quickly each gets into the bloodstream after it is swallowed, and to check for any side effects. For each participant, the study will last about 7 weeks and will include 3 stays in the Clinical Research Unit (CRU). Each stay will last 3 nights.
Timeline
- Start
- 2026-06-03
- Primary completion
- 2026-07
- Completion
- 2026-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY4065967 | Unknown | — | Oral |
Indications
No indication recorded.